MF
Mani Foroohar Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
46.2%
Neutral
38.5%
Negative
15.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $20 |
31%
upside
| 1 | +9.9% |
0
%
| 15 Dec ‘25 23 days ago |
|
|
|
Outperform
Maintained
| $100 |
20%
upside
| 1 | +2.9% |
0
%
| 15 Dec ‘25 23 days ago |
|
|
|
Outperform
Maintained
| $86 |
16%
upside
| 1 | -1.2% |
0
%
| 15 Dec ‘25 23 days ago |
|
|
|
Market Perform
Maintained
| $351 |
17%
downside
| 1 | – |
–
| 15 Dec ‘25 23 days ago |
|
|
|
Underperform
Maintained
| $18 |
50%
downside
| 2 | -23% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $20 |
100%
upside
| 2 | +97% |
0
%
| 7 Oct ‘25 3 months ago |
|
|
|
Market Perform
Maintained
| $7 |
80%
upside
| 2 | -83% |
–
| 3 Oct ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $10 |
57%
downside
| 1 | – |
–
| 21 Jul ‘25 5 months ago |
|
|
|
Market Perform
Maintained
| $6 |
23%
upside
| 1 | – |
–
| 28 Feb ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $27 |
247%
upside
| 1 | +41% |
0
%
| 13 Jan ‘25 11 months ago |
|